Cargando…
Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection
T cells are involved in control of coronavirus disease 2019 (COVID-19), but limited knowledge is available on the relationship between antigen-specific T cell response and disease severity. Here, we used flow cytometry to assess the magnitude, function, and phenotype of SARS coronavirus 2–specific (...
Autores principales: | Riou, Catherine, du Bruyn, Elsa, Stek, Cari, Daroowala, Remy, Goliath, Rene T., Abrahams, Fatima, Said-Hartley, Qonita, Allwood, Brian W., Hsiao, Nei-Yuan, Wilkinson, Katalin A., Arlehamn, Cecilia S. Lindestam, Sette, Alessandro, Wasserman, Sean, Wilkinson, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203446/ https://www.ncbi.nlm.nih.gov/pubmed/33945513 http://dx.doi.org/10.1172/JCI149125 |
Ejemplares similares
-
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
por: du Bruyn, Elsa, et al.
Publicado: (2023) -
Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
por: Riou, Catherine, et al.
Publicado: (2020) -
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
por: Riou, Catherine, et al.
Publicado: (2022) -
Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis
por: Du Bruyn, Elsa, et al.
Publicado: (2020) -
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial
por: Wasserman, Sean, et al.
Publicado: (2021)